Professionals Services Insights Community
About Offices Careers
Home / Insights / DOJ Targets Pharmaceutical ...
PDF

January 2010

Lindsay B. Meyer

DOJ Targets Pharmaceutical & Life Sciences Companies for FCPA Enforcement

Related Services

Practices

Industries

Related Insights

David Barr’s 2026 Edition of PLI Treatise Pharmaceutical and Biotech Patent Law Published
David Barr’s 2026 Edition of PLI Treatise Pharmaceutical and Biotech Patent Law Published

August 27, 2026

1min
AI in development of pharmaceutical compounds
AI in development of pharmaceutical compounds

May 21, 2026

2min
AI and Enablement After Amgen v. Sanofi: Implications for Life Sciences Patents
AI and Enablement After Amgen v. Sanofi: Implications for Life Sciences Patents

October 01, 2025

5min
View More

Recent News

Former Commissioner of the U.S. Securities and Exchange Commission Caroline Crenshaw Joins Venable as a Partner in Washington, DC
Former Commissioner of the U.S. Securities and Exchange Commission Caroline Crenshaw Joins Venable as a Partner in Washington, DC

September 08, 2026

3min
Venable Secures Complete Victory for Greenvision, Including More Than $1.3 Million Attorney Fee Award
Venable Secures Complete Victory for Greenvision, Including More Than $1.3 Million Attorney Fee Award

September 02, 2026

2min
Dan Hayes Shares Insights on SEC’s Enforcement Approach with Barron’s
Dan Hayes Shares Insights on SEC’s Enforcement Approach with Barron’s

August 31, 2026

1min
View More